INTRODUCTION
The introduction will be divided into three sectlons. The firstwill deal with the two-step model for skin tumor formation in mice. The second will review the roJe of the induction of ornithine decarboxylase activity in skin tumor formation. Finally, the evidence foraroJe for Vitamin A in tumor formationwill be presented.
The ultimate goal of this research program is to learn the biochemlcal changes that are essential for the transformation of anormal cell to a tumor cell using the Initiationpromotion (two-step) model system for the production of skin tumors in mice. Toward this goal we will showherein that those retinoids which effectively inhlbit skin carcinogenesis also inhibit the induction of ornithine decarboxylase by the promoting component of the carcinogenic process, a correlation which strengthens the probabillty that increased ornithine decarboxylase activity is essential to carcinogenesis.
The Two-step Model for Skin Tumor Formation Skintumorsare easily produced in an appropriate anlmal by repeated appl ications to the skin of a chemical carcinogen such as benzpyrene. However, there is a model system uslng mice devised by Mottram (1) in which the carcinogen need be administered only once and when followed by twice weekly appl ications of croton oil or its active principle, 12-0-tetradecanoylphorbol-13-acetate, many tumors may result. Neither the single appl ication of the carcinogen nor the multiple appl ications of croton oil cause tumors when one is appl ied wlthout the other. Furthermore, the single appl icatlon of the carcinogen must precede the multiple appl ications of croton oil; if the order is reversed, no tumors result. Thus the terminology, Initiation for the event accomplished by the slngle application of the carcinogen and promotion for the process accompl ished by the croton oll, is generally accepted. Further evidence for the qualitative difference in the nature of these stages arises from the fact that the Initiation step is irreversible in contrast to the reversible nature of the action of promoting agents. The biology of the Initiation-promotion phenomenon has been reviewed (2,3). The two-stage model for the development of skin tumors is a remarkably quantitative model for the study of the process of carcinogenesls and is excellent for the lnvestigation of factors modifying the process of tumor formation.
The Induction of Ornithine Decarboxylase by Tumor Promoters
The biochemistry of the process of tumor promotion has been extensively studied (4). A prominent biochemical response to treatment of mouse skin with a potent tumor promoter such as 12-0-tetradecanoyl-phorbol-13-acetate is the induction of ornithine decarboxylase activity (EC 4. 1. 1. 17). Decarboxylation of ornithine to putrescine is catalyzed by ornithine decarboxylase and is the first and rate-limiting step in the pathway of polyamine biosynthesis. S-Adenosylmethionine decarboxylase (EC 4. J. 1.50) is the second enzymein polyamine biosynthesis and catalyzes the production of the propylamino group which condenses with putrescine to form spermidine and a second propylamlno group condenses with spermidine to form spermine. In general terms these polyamines control the synthesis of nucleic acids and proteins and are involved in cell prol iferatlon and differentation (5).
In a typical experiment, 17 nmol of the tumor promoter 12-0-tetradecanoylphorbol-13-acetate is applied to the skin of the back of a mouse and 4.5 hr later mice are killed, a supernatant solution prepared from the epidermal cells of the treated skin, and the activity of the polyamine biosynthetic enzymes is measured (6). Results of a typlcal experiment are shown in Fig. 1 . Ornithine decarboxylase activity in normal mouse skln is very low, but activity increases rapidly reaching a peak of 250-fold or more of the control Ievel by 4.5 hr and thereafter rapidly returns to normal. The actlvity of S-adenosylmethionine decarboxylase rlses more slowly reaching a plateau about 6 to 7-fold above the control Ievel which is maintained for perhaps 24 hr before decl lning to control Ievel over a period of several days.
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Tumor promoters cause typical pleiotypic effects; they act as reversible derepressors of gene activity. HOURS AFTER 17 nmoles TPA Fig. 1 The effect of a single topical appl ication of 17 nmol of 12-0-tetradecanoylphorobol-13-acetate on the activities of epidermal ornithine decarboxylase and S-adenosylmethionine decarboxylase. Groups of 5 mice were treated once with either 0.2 ml acetone or the phorbol ester dissolved in acetone and killed at the times indicated. The points represent the means of tripl icate determinations of enzyme activity; the variation was less than 10%.
Evidence from dose-response and structure-response studies showed a good correlation between the ability of an agent to induce ornithine decarboxylase activity and to promote tumor formation. In contrast, non-promoting hyperplasiogenic agents induced S-adenosylmethionine decarboxylase activity without inducing ornithine decarboxylase activity. Thus increased activity of ornithlne decarboxylase may be an essential part of the mechanism of promotion, but not so ln the case of the second enzyme (S-adenosylmethionine decarboxylase) in the polyamine biosynthetic pathway.
Retinolds and Tumor Promotion
Further evidence on a possible obl igatory role for increased ornithine decarboxylase activity in tumor formation can be obtained by observing the effect on the activity of the enzyme of agents capable of inhibiting tumor promotion. Specifically, Vitamin A has been shown to inhibit tumor promotion (7). Does vitamin A inhibit the abil ity of the phorbol ester to induce activity of the polyamlne biosynthetic enzymes? This question is the. subject of this paper.
Vitamin A is essential for centroll ing the normal differentiation of many epidermal tlssues (8). In the trachea and bronchi, squamous metaplasia occurs in vitamin A deficiency, a condition mlmicing premal ignancy. In fact those tissues which are most prone to cancer (skin, breast, lung, colon, rectum, pancreas, prostate, and bladder) require vitamin A for normal differentiation.
There are a number of examples of enhanced susceptibil ity to chemical carcinogenesis in vitamin A deficlency (8). Although these observations suggest that increased vitamin A Ievels might preclude the development of tumors, this is not always the case (8). The major problern isthat when administered systemically, the natural retinoids accumulate in the 1 iver with toxic manifestations and without increased plasma retinoid Ievel. Thus problems of toxicity and tissue distribution 1 imit the usefulness of natural forms of vitamin A for the prevention of cancer. However, vitamin A acid (retinoic acid) is not converted to vitamin A (retinol) in the animal body, it is not stored in the liver, and is much less toxic than retinol and its esters. It, together with an analog of retinoic acid,. were used successfully by Bollag (7,9) to inhibit the promotion of skin tumors in mice. Because the mouse skin tumor model which we employ precludes problems of toxicity of retinoids since the retinoids can be applied dlrectly to the site, the model lends itself to the study of the effect of retinoids on tumor formation. Moreover, as described in the previous section, the effect of retinoids on the biochemical response of mouse skln to tumor Initiators and promoters may be easily determlned. Thus the relevance of blochemical observations to the process of tumor formation may be establ ished.
EXPERIMENTS AND RESULTS
The experimental procedures have been fully descrlbed. (6,10,11) and some of the results have been published (10,11).
The basic observation (shown in Fig. 2 ) ls that a very small dose of retlnoic acid applied to the skin inhlbits the induction of ornithine decarboxylase activlty ln the epidermis by the tumor promoting phorbol ester and, using the same protocols, also inhlbits the promotion of epithelial tumors. The data on the Inhibition of enzyme inductlon by retinoic acid is shown in Fig. 2 and the lnhibitory effect on tumor formation ls shown in Fig Fig. 2 The effect of pretreatment with retinolc acld on phorbol esterinduced epidermal ornithine decarboxylase activlty. Groups of mice were treated with 1.7 nmoles of retinoic acid (0) or acetone (I) 1 hr before treatment with 17 nmol of tetradecanoylphorbol acetate. Mice were killed for enzyme assay at the indlcated times after appl ication of the phorbol ester. Each point in the graph represents the average of tripl icate determinations of enzyme activity from soluble epidermal extracts prepared from 4 mice.
As shown in Fig. 2 (also see Fig. 1 ), application of 17 nmol of the phorbol ester to mouse skin caused about a 250-fold increase in ornithine decarboxylase activity of the epidermis between 4 and 6 hours after treatment. In contrast, a much smaller increase in enzyme activity resulted in those mice treated topically with 1.7 nmol of retinoic 1 hour before 17 nmol of the phorbol ester was appl ied to the same area of the skin of the back. Assays for enzyme activity are made on epidermis isolated from the treated skin area in all cases; the area consists of about 12 sq. cm. and is the area over which the test matertals are spread by the solvent, 0.2 ml acetone. In centrast to the abil ity of retinolc acid to inhibit the lnduction of ornithine decarboxylase, the increase in 5-adenosylmethionine decarboxylase actlvity which is induced by the phorbol ester is not inhibited by retinoic acld (data not shown, see ref.
10). The fact that the secend enzyme in the polyamine biosynthetic pathway is not inhibited shows a high degree of specifcity for the retinoic acid effect. The speciflcity is emphasized by the observation that the increased incorporation of trititiated leueine into the total soluble proteins of epidermis which is caused by the phorbol esters is not blocked by retinoic acid. Only a very specific, small part of the total Stimulation is blocked, namely ornithine decarboxylase. 
further circumstantial evidence on the question of the relevance of high Ievels of the enzyme and the formation of tumors. All mice were initiated as described and then treated with the 8 nmol of the phorbol ester twice a week. Mice given no further treatment served as the controls and many tumors developed. Mice in a secend group that were initlated and promoted were treated with 17 nmol of retinoic acid 1 hour before each promoter treatment and there was a dramatic reduction of tumors in these mice (equivalent tothat shown in Fig. 3) . In contrast, a third group of mice were treated with retinoic acid 24 hours after each promoter treatment (a regimen which does not inhibit the induction by phorbol ester of ornithlne decarboxylase) and the tumor incidence was high, the same as in those micenot treated with retinoic acid. These results show that the time at which the retinoic acid is applied relative to the time of phorbol esters is critical to the Inhibition of tumors; the timing correlates with the timing required to inhibit ornithine decarboxylase induction and, therefore, the results support an obligatory role for the induction of the enzyme in the biochemical m~'anism of skin carcinogenesis.
Dose-response studies showed that the inhibitory effect of retinoic acid on ornithlne decarboxylase induction was barely discernable at 0.0034 nmol of retinoic acid. Increasing doses, appl ied one hour before the.phorbol ester, caused an increaslng Inhibition of induction and at doses of 3-4 nmol essentially no induction was detectable (10). A 50% Inhibition was achieved with a dose of about 0.17 nmol of retinoic acid applied in 0.2 ml of acetone to the skin of the back in the same area to which 17 nmol of 12-0-tetradecanoylphorbol-13-acetate in 0.2 ml of acetonewas applied one hour later.
In centrast to the broad range of effective dose of retinoic acid applied topically, the doseresponse curve for orally administered retinoic acidwas much sharper (10). As in the topically appl ied tests, the retinoic acid administered by stomach tube (in 0.2 ml corn oll) was given one hour before the phorbol esterwas appl ied to the skin. Mice were killed for ornithine decarboxylase assay 4.5 hr after the phorbol ester. Doses of retlnoic acid below 0.034 ~mol were ineffective but between 0.034 ~mol and 0.34 ~mol there was a dose-dependent Inhibition of enzyme with a 50% inhibitory dose at about 0.17 ~mol retinoic acid. In summary, orally administered retinoic acid effectively inhiblted enzyme lnduction when administered only one hour before the topical application of the inducing agent; the amount of retinoic acid required for 50% Inhibition was 1000-fold larger by the oral route and the dose-response curve was much steeper for orally-admlnlstered retinoic acid.
A number of natural and synthetic retinoids were tested for their abll ity to inhibit the induction of ornithine decarboxylase activity and for their inhibitory effect on tumor formation. Dose response curves were determined for the inhibitory effect of each of the retinoids, topically appl Ted, on the enzyme induction (11). This allowed a rational choice of dose for the tumor studies. The results of these dose-response studies on the Inhibition of enzyme induction by 23 synthetic retinoids tagether with the structure of the compounds is presented in Flg. 4. The mean inhibitory dose for each retinoid is given.
A number of representative synthetic analogs of retinoic acid were tested for their effect on the incidence of skin papillomas when administered one hour before each of the twlce weekly appl icatlons of 8 nmol of the phorbol ester. Results of a typical experiment are shown in Fig. 5 (12) . The conclusion from these experiments isthat there is a close parallel ln the abil ity of the synthetic retinoids to inhibit the induction of ornithlne decarboxylase activity and to inhibit tumor formation. None of these retlnoids inhibited the induction of S-adenosylmethionine decarboxylase activity.
There was a similar parallel in the abil ity of the natural retinoids to inhlbit both the induction of the enzyme and the promotion of tumors by the phorbol ester. The Inhibition of the phorbol ester-induced ornithine decarboxylase activity is shown in Table 1 . The ability of these retinoids to inhibit tumorformationwas proportional to their ability to inhibit the induction of the enzyme (10). 
(2)
4 8 12 16 20 WEEKS OF PROMOTION Fig. 5 The effect of varlous retinoids on skin tumor promotion. All mice were initiated with a single application of 0.2 ~mol of 7,12-dimethylbenz[a]anthracene. After 2 weeks all mice were promoted with twice weekly appl ications of 8 nmol of the phorbol ester for 20 weeks. Retinoids were appl ied one hour before each phorbol ester appl ication, except the control group of mlce (group 6) were pretreated with acetone solvent only. Doses for retinoids were 34 nmol for ß-retinoic acid and 13-cls-retinoic acid, and 140 nmol for the trimethylmethoxyphenyl (TMMP~nalog of ethyl retinoate, the trimethylhydroxyphenyl (TMHP) analog of ethyl retinoate, and the 13-trifluoromethyi-TMMP analog of ethyl ret i noate. · 42 100 100
1. The retinoids were appl ied to the skin in 0.2 ml of acetone 1 hour before the application of 17 nmoles of the phorbol ester in 0.2 ml acetone.
2. The phorbol ester-induced Ievel of ornithine decarboxylase activity was set at 100.
DISCUSSION
There is considerable evidence that the induction of epidermal ornithine decarboxylase activity and the resultant increase in tissue Ievel of the polyamines, particu1arly putrescine, may be an essential metabol ic component of the process of skin carcinogenesis (13). All tumor promoting stimul i that have been tested accomplish the induction, particularly 12-0-tetradecanoylphorbol-13-acetate. The degree of induction parallels the abil ity of the test substance to elicit skin tumors in initiated skin. Hyperplaslagenic agents that do not promote do not induce the enzyme. The correlation is strengthened by the observation that retlnoids inhibit the induction, and in addition the Inhibition parallels the Inhibition of tumor formation by the retinoids which have been tested.
Retinoids have been lang associated with the control of normal differentiation of epithelial tissue (8). In contrast, the process of tumor promotion, accompl ished so effectivey by mieregram quantlties of 12-0-tetradecanoylphorbol-13-acetate, has been thought to involve a bleck of terminal differentiation. The increased Ievels of putrescine observed after phorbol ester treatment may be responsible. In any case, the fact that vitamin A-active compounds are capable of antagonizing the biochemical response that appears to be characteristic of an agent which blocks terminal differentiation and whose biochemical and morphological consequence is to cause cells to mirnie the tumor cell phenotype after a single dose, suggests that the observed metabol ic effect of retinoids may be a streng clue to their biochemical mechanism of action. It is very important to pursue the role of retinoids in cantroll ing the putrescine Ievel of epithelial tissues and the biological significance of that cont ro 1 • In addition to contributing to the understanding of the mechanism of carcinogenesis, these studies suggest that a simple, rapid, and inexpensive method for testing the antipromoting properties of synthetic retinoid~ as weil as retinoid metabolites may be developed based on Inhibition of ornithine decarboxylase induction. One of the advantages of the proposal is that it is a test using intact mice in an organ system in which the retinoids actually function to inhibit tumor formation. A number of ~est systems now exist based on reversal of the metaplasia of vitamin A deficient hamster trachea in organ culture (13), reversal of carcinogen-induced hyperplasia of mause prostate organ cultures, and other biological systems. The activity of a number of retinoids have been assayed in both the hamster trachea test (13, and personal communication) and the ornithine decarboxylase test. Agreement is good. There may be discrepancies in a few retinoid derivatives that arenot metabol ized to active forms when topically applied to mause skin; for example, we found that an amidederivative of retinoic acidwas a very effective Inhibitor of phorbol ester-induced ornithine decarboxylase activity if administered orally but the samederivative was at least three orders of magnitude less effective than retinoic acid if applied topically (11). We conclude that some retinoids should be tested by the oral raute as weil as by local appl ication to provide a valid assay of potency.
Currently there is great interest in the role of retinoids in the Inhibition of carcinogenesis, both as useful agents to study for elucidating the biochemical mechanism of carcinogenesis and for practical application for prophylaxis against certain human cancers (8, 15). However, there have been two recent reports in which it has been suggested that the prophylactic appl ication of retinoids in human neoplasia may be i 11-advised (16, 17) . Certainly when one is dealing with agents that are as powerful as the retinoids, capable of altering basic processes of differentiation, caution and full understanding areessential before human use. In both cases which led to the suggestion for caution, there is the possibility that the authors overinterpreted their results. The model systems used cultured fibroblasts rather than epithelial cells, the Ievels or retinoids were high (1000-fold or more higher than the Ievels shown to inhibit metaplasia in the master trachea) and probably toxic, and the effects were not correlated with effects on tumor formation. In contrast, differentiation of teratocarcinoma stem cells by retinoic acidwas reported in a paper (18) publ ished immediately adjacent to one of those urging caution (17) and the abil ity of retinoids to block phenotypic cell transformation caused by sarcoma growth factor (19) was publ ished immediately adjacent to the other (16) . Obvlously, more research is essential to resolve the role of retinoids in centroll ing differentiation and preventing cancer.
SUMMARY
A diterpene, 12-0-tetradecanoylphorbol-13-acetate is capable of eliciting many tumors of the skln of mice previously exposed to a carcinogen at a noncarcinogenic dose. The same agent also causes an increase of 250-fold or more in the activity of ornithine decarboxylase activity in the epidermis of mice within 5 hours after the application of 8.5 nmoles of the diterpene to the skin. Structure-activity and dose-response studies show that the induction of the enzyme may be an essential component of the biochemical mechanism of skin carcinogenesis. Further evidence that the induction of epidermal ornithine dearboxylase actvitiy may be one of the biochemical events essential for skin tumorformationwas obtained from studies on Vitamin A and its analogs (retinoids). The ability of a !arge number of retinoids to inhibit the induction of ornithine decarboxylase activlty in mouse epidermiswas studied. Several of the same retinoids were tested for their ability to inhibit phorbol ester-promoted skin tumors. It was found that those retinoids that are the most effective as Inhibitors of the enzyme induction arealso the most effective Inhibitors of tumor formation. The possibil ity that increased Ievels of the polyamine biosynthetic enzyme, ornithine decarboxylase, may play an obl igatory role in the mechanism of carclnogenesis was strengthened by these data on the effects of retinoids. In addition, it is proposed that Inhibition of the induction of this enzyme by retinoids in intact mouse skin may provide a simple and rapid test system for determining the tumor inhibitory activlty of new synthetic retinoids.
